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MinireviewResistance Is Futile:
Assimilation of Cellular Machinery
by HIV-1
the Gag structural proteins (group-specific antigens).
Retroviral Gag proteins have a specific region referred to
as the late assembly (L) domain—required for retroviral
budding. “L” domains are proline containing sequence
motifs found in several retroviral classes. These include
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the P(T/S)AP motif of the HIV-1 p6Gag, the PPPPY motif
of the avian retrovirus p2bGag, the PY motif of the murine
moloney leukemia virus (MMLV) p12Gag and the pp16GagHIV-1 budding appears to require Vps4 and Tsg101—
protein of Mason-Pfizer monkey virus, and the YPDLtwo proteins that have links to endosomal sorting ma-
motif in the C-terminal Gag protein of the distantly re-chinery. A picture emerges wherein divergent viruses
lated equine infectious anemia virus (EIAV) (Strack etrecruit endosomal proteins like Tsg101 to gain access
al., 2000; Vogt, 2000).to ubiquitin processes that play a crucial role during
These viral-specific sequences, PTAP (consensusviral budding.
P(T/S)AP), YPDL (consensus YXXL), and PPPY (consen-
sus PxPY), represent three types of retroviral Gag LExploitation of cellular resources by viruses, namely
domain proteins. The HIV p55Gag protein is initially aHIV-1, is not a new concept. The genetic material of this
contiguous polypeptide product that is proteolyticallyRNA-based virus encodes necessary structural compo-
cleaved during later stages of virion production to yieldnents, enzymes for viral replication, and auxiliary pro-
the core structural components (p17/matrix, p24/cap-teins. Inherent however in the structure of the expressed
sid, p7/nucleocapsid, and p6 proteins). HIV Gag poly-proteins are template-driven instructions for interac-
proteins are synthesized and targeted to the plasmations with cellular constituents that serve in the produc-
membrane where they take part in viral assembly andtion of infectious viral particles. Intensive research has
only begun to uncover the molecular details of the host- subsequent budding. Evidence suggests that the viral
cell processes utilized by the HIV-1 virion during, for particle is not released until the late L domain, a motif
instance, the latter phases of viral release. Garrus et al. present within HIV-1 p6Gag, becomes available (Patnaik
(2001) identify vacuolar protein sorting (Vps) constit- et al., 2000). Mutational analysis of the sequence motifs
uents, Tsg101 and Vps4, to be necessary for HIV-1 viral involved in late budding domains of the Gag proteins
budding. The findings expose an interesting stratagem of several viruses has been correlated with budding
by which HIV-1 harnesses the endosomal protein ma- defects for HIV-1 (Ott et al., 2000, and references
chinery for the finalization of the budding process during therein), SIV (Gonzalez et al., 1996), MMLV (Yuan et al.,
virion maturation. 2000), EIAV (Puffer et al., 1998, and references therein),
Replicative infection by HIV-1 is a multistep process RSV (Strack et al., 2000), and recently for Ebola, vesicu-
that occurs in several arbitrarily defined stages: (1) en- lar stomatitus virus (VSV), and rabies virus (RV) (Harty
trance (cell binding, fusion, and penetration), (2) propa- et al., 2001, and references therein). The question arises
gation (integration, transcription, protein production, as to whether these various viruses share the same host
and virus particle assembly), (3) budding (packaging and pathways or proteins for virion budding or rather exit
egress from cellular confines), and (4) postbudding mat- the cell by divergent mechanism despite the tantalizing
uration (reorganization of virion architecture). From viral similarities.
entry to release there are fascinating examples of ex- The field began to gain clarity when it was realized
ploitative redirection of cellular proteins to facilitate vi- that ubiquitin was required for retrovirus budding, that
rion replication. There is the well-studied example of the L domains were important to allow correlated ubiqui-
CD4/CCR5 “assisted” entry of the virus into T cells. tylation of the viral Gag proteins, and, interestingly, that
Examples of chromatin-remodeling machinery hijacking ubiquitylation of the Gag proteins on target lysines was
for integration have been reported (Turelli et al., 2001). proximal to the L domains in some viruses. This built
Other studies have illustrated an intrinsic dependency on a much earlier understanding that avian retroviruses
on a functionally responsive host cell (Kinoshita et al., contained an unusual amount of ubiquitin (Putterman et
1998). al., 1990). Ubiquitin was involved—but how? Ubiquitin
The complete list of cellular systems that HIV-1 must is a well-known 76 amino acid protein that can become
exploit to allow its replication is as yet unappreciated. conjugated to the -NH2 group of the lysine residues
In this context, the work by Garrus et al. (2001) offers a through the action of ubiquitin-modifying enzymes. Ubi-
new way to look at the final stages of virus replication, quitinylation of target substrates is orchestrated by a
directing future inquiries toward the endosomal protein concerted mechanism involving E1 (ubiquitin-activating
machinery in order to further understand the budding enzymes), E2 (ubiquitin-conjugating enzymes), and E3
of a number of viruses, including that of HIV-1. (ubiquitin-ligase). There are multiple E2 and E3 proteins.
Polyubiquitylation is most widely known for its role in
Retroviral Budding and Ubiquitylation directing proteins for degradation. However, in recent
A culminating step during viral production is exit from years ubiquitylation has been understood to have wider
the cells. This budding event shields the viral core with roles in protein rerouting though the vesicular compart-
ments of the cell with monoubiquitylation gaining atten-
tion as a specific protein modification involved in distinct1 Correspondence: gnolan@stanford.edu
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proteosome-independent cellular processes that in- tains the region that binds the PTAP region of HIV-1
p6Gag. They illustrated that lysine residues near the PTAPclude histone regulation, endocytosis, and other pro-
cesses. motif of the HIV-1 p6Gag protein can be monoubiquitiny-
lated in vitro and that this modification can enhance theData emerged that ubiquitin-conjugating activities are
part of the retroviral budding machinery for RSV (Patnaik affinity of Tsg101 and HIV-1 p6Gag in vitro. Thus, there
might be a role for ubiquitylation in luring in machineryet al., 2000), with concommitant studies confirming
monoubiquitylation of HIV-1 p6Gag and MMLV p12Gag (Ott that communicates with vesicular trafficking.
Garrus et al. (2001) demonstrate a cellular requirementet al., 2000), SIV (Strack et al., 2000), and the Ebola
virus in vitro (Harty et al., 2000). That said, although of Tsg101 in HIV-1 budding by depleting Tsg101 with
small interfering RNAs (siRNA) from a model 293 cellubiquitylation of HIV-1 p6Gag and MMLV p12Gag was ob-
served, mutations in the corresponding ubiquitylation system. Depletion of Tsg101 decreased viral titers by
10- to 50-fold and strongly inhibited viral release. Rein-target lysine residues demonstrating that monoubiquity-
lation was not necessary for viral replication (Ott et al., troduction of a recombinant Tsg101 protein, which was
resistant to siRNA action, phenotypically rescued HIV-12000). However, depletion of intracellular levels of ubi-
quitin did inhibit both the retroviral budding process of viral budding. Use of a dominant-negative version of
Vps4, an ATPase that can disassemble endosome asso-HIV-1 budding and monoubiquitylation of HIV-1 p6Gag
(Schubert et al., 2000). Further, a direct role of the Ub ciated Vps complexes, also blocked HIV-1 release in
vivo. Thus it seems that Vps4 and Tsg101 participatemachinery, the RSV L domain, interacts with both the
ubiquitin protein ligase Nedd4 as well as a related ubi- in a common pathway, as DN-Vps4 cells and Tsg101
depleted cells show incomplete budding of HIV-1 virionsquitin ligase termed late domain interacting protein
(LDI-1) (Kikonyogo et al., 2001). Neither protein inter- in infected cells.
A pivotal finding by Garrus et al. (2001) is that DN-Vps4acted with RSV L domain mutants known to be critical
for L domain function in vivo, nor could they interact blocked both HIV-1 and MMLV viral budding, although
Tsg101 depletion did not block MMLV (most likely duewith L domain peptides from the HIV-1 p6Gag or EIAV
(Kikonyogo et al., 2001). Thus, the findings suggested to MMLV p12Gag containing the PY motif and not the
PTAP motif). These striking results suggest that diver-that different retroviral L domain sequences interact with
distinct host proteins involved in the ubiquitylation to gent retroviral L domains mediate budding through a
shared Vps pathway—and differ only in the substrate-allow retroviral budding. Further, the results suggested
that although ubiquitylation activity is important for bud- specific interacting proteins that mediate aspects of this
recognition.ding—and the L domains of several enveloped viruses
can functionally substitute for each other in allowing Notably, the yeast homolog of human Tsg101, Vps23,
has recently been demonstrated to interact with a 350productive viral budding and Gag ubiquitylation—the
ubiquitylation of the L domain itself was not required kDa protein complex ESCRT-1 (composed of Vps23,
Vps28, and Vps37) whose function is required for endo-for the budding process. Thus, protein(s) that recruit a
necessary ubiquitin-conjugating activity require the L somal protein sorting (Katzmann et al., 2001). ESCRT-1
participates in the multivesicular body pathway (MVB) indomains and play a crucial role in the budding process.
The hypothesis arose that L domains engage ubiquitin both yeast and mammalian cells, an endosomal system
that is responsible for surface receptor downregulationligase machinery (either directly or through adaptor pro-
teins) and that the ubiquitylation process somehow facil- and lysosomal/vacuole traffic. Interestingly, both Vps4
(yeast and mouse ortholog SKD1) and Tsg101 (human,itates budding (Vogt, 2000). But how does this tie in to
membrane-budding machinery? mouse, and yeast homologs) mutants display defects
in MVB processing (Babst et al., 2000; Scheuring et al.,It is at this point that the work by Garrus et al. (2001)
creates a link by demonstrating that two proteins with 1999). Katzmann et al. (2001) demonstrated that ubiqui-
tin serves as a signal for protein sorting into the MVB,ties to vacuolar protein sorting, Tsg101 and Vps4, point
to a dependency on the Vps pathways for HIV-1 viral a process that topologically mimicks viral budding.
Thus, the role of the ESCRT-1 complex (which containsbudding. Tumor susceptibility gene 101 (Tsg101) was
originally identified as a cellular transforming gene in a the Tsg101 homolog Vps23) in ubiquitylated cargo rec-
ognition is a striking parallel with the findings of Tsg101genetic screen (Li and Cohen, 1996) and has homology
to several inactive ubiquitin-conjugation enzymes iden- and Vps4 in HIV-1 budding by Garrus et al. (2001), show-
ing that multiple Vps pathway constituents may be par-tified in yeast as being important for late endosomal
trafficking (Babst et al., 2000). Tsg101 positively regu- ticipating in retroviral budding. A model as to the role
the Vps pathway may possess for retroviral budding islates lysosomal degradation of some cell surface pro-
teins, and Tsg101 mutant cells have been shown to be presented in Figure 1.
Tsg101 did not appear to be involved in the buddingdefective in the delivery of proteins to late endosomal
compartments, controlling the fate of proteins through of a distantly related retrovirus MMLV. The evolutionary
divergence is a significant distinction, suggesting thatdegradative processes, and demonstrating its connec-
tion with the vacuolar protein sorting machinery (Ruland Tsg101 is not functionally involved in all retroviral bud-
ding processes per se but in fact is exclusive to HIV-1et al., 2001).
Tsg101 was previously found to bind the L domain (and perhaps a few other retroviruses). In a similar re-
spect, EIAV, an evolutionary lentiviral cousin of HIV-1,of HIV-1 Pr55Gag in a yeast-two hybrid screen and that
interaction was verified to be between the HIV-1 p6Gag contains a YXXL motif in its Gag molecule that has been
shown to be critical for both viral release and interac-PTAPP L domain and Tsg101 both in vitro and in vivo
(VerPlank et al., 2001). Garrus et al. showed that tions with AP50 (Puffer et al., 1998), a component of the
AP-2/Clathrin-coated pits, that aids in the viral endocyticTsg101’s ubiquitin enzyme 2 variant (UEV) domain con-
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Figure 1. Model for HIV-1 Utilization of Vps Machinery
HIV-1 infects target cell, integrates into genome, and begins replication cycle. Viral proteins are synthesized, processed, and p6Gag recruits
Tsg101 to the site of budding (ubiquitin [Ub] p6Gag prior to or postbinding of Tsg101 may enhance this interaction). One model is that Tsg101
is brought to the virion and then in some manner recruits the Vps machinery. Once recruited, the Vps machinery, either alone or in concert
with viral proteins or other recruited structures, creates a viral core that is competent for budding. A Vps pathway that includes the protein
Vps4 was shown to be involved by expression of dominant-negative allele of Vps4. The manner in which Vps4 involves itself in the process
is not clear, though it appeared that dnVps4 could inhibit both MLV as well as HIV-1 budding processes. Only a fraction of the viral Gag
proteins are ubiquitinated, and it is still not clear whether this is directly involved in budding, serves a role recruiting essential machinery, or
is a bystander outcome to other necessary ubiquitylation processes.
compartmentalization and subsequent budding. Func- complexity of this process likely involves other cellular
factors. Appreciation of the in vivo molecular events oftionally equivalent proteins to Tsg101 remain to be dis-
covered for other viruses, to serve as “adaptor” proteins ubiquitinylation of HIV-1 p6Gag and intracellular interac-
tions of ub-p6 and Tsg101 in human T cells may providebetween viral Gag proteins and endosomal constituent
proteins. Thus, the findings that retroviral budding is mechanistic details of how these events are required
for viral release in cells that are typically infected by aVps pathway dependent for divergent viruses suggests
that it is an evolutionary conserved mechanism that HIV-1 in vivo.
Key questions remain in this story. It is still not clearsome viruses can use for budding.
It has been proposed by several investigators that the what the role of ubiquitylated Gag might be. Is it required
for the process of budding or is Gag ubiquitylation inci-budding of enveloped viruses from the plasma mem-
brane is topologically equivalent to the budding of vesi- dental to the ubiquitylation of some other protein during
budding? Is Tsg101 required for engaging the ubiqui-cles into the lumen of late endosomes. In support of
this, the ubiquitylation of the HIV-1 p6Gag protein does not tylation machinery or is it simply a docking protein that
carries the immature virion to some appropriate placedestine p6Gag for proteolytic degradation by packaging it
into endosomal compartments, contrasting the effect in the cells? Is Tsg101 contained within an ESCRT-like
complex in cells? Does it partake directly in proteinubiquitylation has on several mammalian cell surface
receptors (Rocca et al., 2001). A pressing question is retargeting or does it play a role in endosome trafficking?
How are Vsp4 and Tsg101 related? Which is upstreamthen why doesn’t the ubiquitin machinery mediate endo-
cytic internalization of the Gag protein complex into an of the other? Or are there parallel tracks in which they
engage themselves? It is simply that ubiquitylation is anendosome? What is the intrinsic difference about the
HIV-1 p6Gag interaction with Tsg101 that directs the ubi- incidental bystander to the vacuolar trafficking process
that appears to result in budding or is it somehow direct-quitin-mediated machinery to expel rather than internal-
ize the mature virus? The findings of Garrus et al. prompt ing the assembly of proteins and membranes via surro-
gates?investigation into the molecular details and suggest the
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native contexts. But, as is well understood in medicinal
pharmacology, favorable drug action is almost always in
competition with deleterious side effects. Despite these
potential caveats, exciting possibilities exist in dis-
rupting the viral::host cell protein interfaces by small
molecules and/or peptides using the combinatorial
chemistry and biology techniques available today. This
is especially true given that the pocket of Tsg101 ap-
pears to be a former site of catalytic action (in evolution-
ary days gone by), and several pharmaceutical compa-
nies are taking an enlightened look at the ubiquitin ligase
family of proteins as drug targets for a variety of human
disorders. Targeting HIV-1’s redirection of the Vps path-
way, or other host-dependent processes necessary for
its own propagation, offer potential and exciting possi-
bilities for the development of powerful anti-HIV regi-
mens. Resistance to assimilation may not, after all, be
futile.
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